Medi-Caps Ltd's earnings have declined by -242.1%, whereas share price has appreciated 10.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.
Medi-Caps Ltd share price has appreciated 11.4% annually (CAGR) over the past ten years.
Data is not available for this company.
Medi-Caps incorporated in 1986 is a flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. Medi-Caps entered the highly competitive market with a team of dedicated professionals, duly supported by competent individuals in every aspect of operation.
Medi-Caps Groupâ€™s activities span manufacturing of Hard Gelatin Capsule Shells, Education, Industrial
Medi-Caps Groupâ€™s activities span manufacturing of Hard Gelatin Capsule Shells, Education, Industrial Packaging & related products, Finance, Real Estate and is a renowned name in central India.
At Medi-Caps a philosophy of growth has been consistently upheld with good business practices. Clear focus, excellent infrastructure, a powerful quality policy and a well defined management information system have helped the company to achieve consistent growth. Today they offer printing features that are best in the industry. Medi-Caps has pioneered many advanced features in product development such as â€œPearlz Capsulesâ€ (Metallic Colored) as well as Python Printing & Li-Fill Caps.
Medi-Caps Limited continuously strives to offer its customers excellent product, technical advice, and a through professional service that makes their product tailor made for their customers both in India as well as abroad.
Their professional goals and corporate personality have blended so well that today Medi-Caps name has become synonymous with the best in the Industry.
Product range of the company includes:
The product product range comprises of six sizes ranging from 00,0el, 0, 1el, 1,2,3,4 in more than 1000 shades, the same is increasing as rapidly as Pharma Industry itself.